EPCAM and neoplasm: The cancer cell subtypes showed a large degree of patient specificity which is in line with recent work published by Izar et al. [29], who investigated the expression of 6 types of EPCAM+ tumour cells from ascites of HGSTOC patients, as well as with multiple single-cell analyses on other epithelial cancer cells [95, 96].